Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Birkmayer

Showing results (71-80 of 75) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 75 results.
Journal of Neural Transmission. Supplementum|January 1, 1978
CNS Modulation of adrenal tyrosine hydroxylase in Parkinson's disease and metabolic encephalopathiesP Riederer, W D Rausch, W Birkmayer, et al.
Journal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1989
The coenzyme nicotinamide adenine dinucleotide (NADH) improves the disability of parkinsonian patientsW Birkmayer, G J Birkmayer, K Vrecko, et al.
Journal of Neural Transmission|January 1, 1985
Increased life expectancy resulting from addition of L-deprenyl to Madopar treatment in Parkinson's disease: a longterm studyW Birkmayer, J Knoll, P Riederer, et al.
Journal of Neural Transmission|January 1, 1978
On the mode of action of L-deprenyl in the human central nervous systemP Riederer, M B Youdim, W D Rausch, et al.
Advances in Neurology|January 1, 1983
Combination treatment with selective monoamine oxidase inhibitors and dopaminergic agonists in Parkinson's disease: biochemical and clinical observationsP Riederer, K Jellinger, W Danielczyk, et al.
Pageof 8

Showing results (71-80 of 75) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 75 results.
Journal of Neural Transmission. Supplementum|January 1, 1978
CNS Modulation of adrenal tyrosine hydroxylase in Parkinson's disease and metabolic encephalopathiesP Riederer, W D Rausch, W Birkmayer, et al.
Journal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1989
The coenzyme nicotinamide adenine dinucleotide (NADH) improves the disability of parkinsonian patientsW Birkmayer, G J Birkmayer, K Vrecko, et al.
Journal of Neural Transmission|January 1, 1985
Increased life expectancy resulting from addition of L-deprenyl to Madopar treatment in Parkinson's disease: a longterm studyW Birkmayer, J Knoll, P Riederer, et al.
Journal of Neural Transmission|January 1, 1978
On the mode of action of L-deprenyl in the human central nervous systemP Riederer, M B Youdim, W D Rausch, et al.
Advances in Neurology|January 1, 1983
Combination treatment with selective monoamine oxidase inhibitors and dopaminergic agonists in Parkinson's disease: biochemical and clinical observationsP Riederer, K Jellinger, W Danielczyk, et al.
Pageof 8